Projects (1334)

T1D-Plus: a clinical trial platform for combined beta cell preservation therapy  (01/09/2022  -  31/08/2026)

T1D-Plus: An adaptive trial platform for the study of combination therapies in new-onset T1D  (01/12/2023  -  30/11/2026)

T1D UK Clinical Trials consortium - mechanistic core  (01/01/2015  -  05/12/2021)

T1D UK Immunotherapy Consortium: Clinical Engagement and Training (CET) Core  (01/05/2015  -  30/03/2020)

Tackling epidemic threats byadvancing the science of humaninteractions and infection  (01/09/2024  -  31/05/2025)

Tackling Radicalisation in Dispersed Societies  (01/08/2012  -  31/07/2015)

TACTICC study  (01/06/2015  -  31/12/2016)

Taffs Well Thermal Spring - Heat recovery  (14/10/2019  -  30/03/2020)

Tai Ffres Research and Evaluation  (01/02/2023  -  31/07/2024)

Tailored OligoG in the treatment of chronic infectious biofilms  (27/11/2013  -  30/06/2017)

Tailored quantum structures  (01/06/2013  -  31/05/2015)

Taith Mobility Programme  (01/09/2022  -  31/08/2025)

Take home naloxone Intervention Multi centre Emergency setting feasibility trial (TIME)  (01/03/2018  -  31/08/2020)

Taking registered reports to the next level  (01/10/2020  -  30/09/2023)

Talking about HPV related cancer: Development and testing of scripted consultations  (01/07/2014  -  30/06/2016)

Talking changes: Developing best practice in co-producing well-being outcomes with looked-after children in Wales  (01/10/2017  -  27/06/2022)

Talking Trials: Exploration of clinical trial perceptions amongst BAME communities  (01/04/2020  -  31/03/2022)

Talking Trials: Participatory approaches to creating community dialogue  (01/10/2022  -  31/01/2024)

Talk Relationships Young Persons Participation Toolkit  (01/11/2024  -  28/02/2025)

Talybont Taste & Odour Event (summer 2024):Data review and research gaps  (16/01/2025  -  15/07/2025)

Tamil temple towns: Conservation and contestation  (14/02/2018  -  28/05/2023)

Tangible Interfaces for Assiting Young People with Neurodiversity Towards better Understanding Online Harms  (01/01/2024  -  31/12/2026)

Tanzanian Onshore Palaeogene Integrated Coring  (01/06/2014  -  31/05/2015)

TAP Centre  (01/01/2020  -  31/12/2022)

TAPERS study Excess Treatment Costs  (01/10/2018  -  31/01/2022)

Targeted drug delivery to the cornea of the eye via medicated contact lenses and mucoadhesive thin films  (01/02/2019  -  28/12/2022)

Targeted drug delivery to the cornea of the eye via thin-film slow release technology  (01/05/2017  -  31/08/2018)

Targeted metabolic inhibition of T-lymphocytes: Directing immunity during human disease  (01/10/2016  -  15/11/2018)

Targeted stabilisation of human cardiac ryanodine receptors as a therapeutic strategy for cardiac disease  (01/10/2009  -  30/09/2014)

Targeted vaccines for infectious disease and cancer  (01/04/2010  -  30/09/2010)

Targeted vaccines for infectious disease and cancer  (31/03/2010  -  30/09/2012)

Targeting alpha-beta - crystalline (CRYAB): A novel strategy to impede triple-negative breast cancer development  (01/07/2014  -  31/01/2016)

Targeting aquaporins function with organometallics: New tools in chemical biology and cancer therapeutics  (01/04/2017  -  30/04/2020)

Targeting cartilage regeneration in joint and intervertebral disc diseases  (01/03/2015  -  28/02/2019)

Targeting CD200 signalling to overcome cell carcinoma immune evasion  (01/01/2014  -  31/07/2017)

Targeting CD8 using “blocking anti CD8 antibodies” as a strategy to disable autoreactive CD8+ T-cells in Type 1 diabetes  (01/01/2023  -  29/02/2024)

Targeting CLL cell survival and proliferation with bioactive cell penetrating peptides  (01/10/2010  -  30/04/2014)

Targeting common mechanisms of pathogenesis in diseases of sterol homeostasis associated with lysosome dysfunction development of novel and rapidly translatable clinical therapies (STEROLOSOM)   (01/06/2012  -  31/05/2014)

Targeting complement to treat fatty liver disease  (01/10/2022  -  30/09/2025)

Targeting Coronaviruses through Fc-dependent Antibody Activities  (01/03/2025  -  29/02/2028)

Targeting CtIP to sensitise cancer cells to DNA-damaging agents  (01/11/2016  -  31/03/2018)

Targeting ERK signalling to ameliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2  (01/11/2019  -  31/10/2025)

Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2  (01/11/2019  -  31/10/2025)

Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2  (01/11/2019  -  31/10/2025)

Targeting glucose metabolism for the treatment of Birt Hogg Dube Syndrome  (01/10/2009  -  30/09/2010)

Targeting G-quadruplex nucleic acid structures with caffeine gold compounds for cancer treatment  (01/10/2016  -  22/12/2017)

Targeting islet-specific CD8 Tcells in Type 1 diabetes  (01/06/2015  -  31/01/2019)

Targeting long-term responses to chemotherapy through a novel stem/immune-related vulnerability in triple negative breast cancer  (23/03/2023  -  22/03/2026)

Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma  (01/10/2019  -  30/12/2022)